MOLECULAR DIAGNOSIS AND TYPING OF LUNG CANCER VARIANTS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14334855

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compositions and methods useful in determining the major morphological types of lung cancer are provided. The methods include detecting expression of at least one gene or biomarker in a sample. The expression of the gene or biomarker is indicative of the lung tumor subtype. The compositions include subsets of genes that are monitored for gene expression. The gene expression is capable of distinguishing between normal lung parenchyma and the major morphological types of lung cancer. The gene expression and somatic mutation data are useful in developing a complete classification of lung cancer that is prognostic and predictive for therapeutic response. The methods are suited for analysis of paraffin-embedded tissues. Methods of the invention include means for monitoring gene or biomarker expression including PCR and antibody-based detection. The biomarkers of the invention are genes and/or proteins that are selectively expressed at a high or low level in certain tumor subtypes. Biomarker expression can be assessed at the protein or nucleic acid level.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF UTAH RESEARCH FOUNDATION615 ARAPEEN DRIVE SUITE 310 SALT LAKE CITY UT 84108
THE UNIVERSITY OF UTAH615 ARAPEEN DRIVE SUITE 310 SALT LAKE CITY UT 84108

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BERNARD, PHILIP SALT LAKE CITY, US 4 45
HAYES, DAVID N CHAPEL HILL, US 4 26
PEROU, CHARLES M CHAPEL HILL, US 32 235

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation